Advanced in Sinus of Valsalva Aneurysm

Ken Kato

Department Of Head And Neck, 5-1-1 Tsukiji, 
Chuo, JP 
Advanced in Sinus of Valsalva Aneurysm
Department Of Head And Neck, 5-1-1 Tsukiji, 
Chuo, JP 
OverviewLocationsClinical Research

Overview

Ken Kato practices in Chuo, Japan. Mr. Kato is rated as an Advanced expert by MediFind in the treatment of Sinus of Valsalva Aneurysm. His top areas of expertise are Esophageal Cancer, Gastroesophageal Junction Cancer, Stomach Cancer, Endoscopy, and Tissue Biopsy.

His clinical research consists of co-authoring 437 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Sinus of Valsalva Aneurysm.

Gender
Male

Locations

Department Of Head And Neck, 5-1-1 Tsukiji, Chuo, 1040045, Japan
Other Locations
Chiba, Japan
Osaka, Japan
Tokyo, Japan
Chuo, 5400006, Japan
Chuo, 2608670, Japan
Sapporo, Japan
Department Of Head And Neck, Chuo, Japan
Tsukiji, 1040045, Japan
Sayama, Japan
Kawahara, 6068507, Japan
Japan
Nagoya, Japan
Showa, Japan
Toyoake, Japan
Kyoto, 1040045, Japan
Yushima, 1138519, Japan
Okazaki, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Drug, Biological
Study Drugs: Cisplatin, Capecitabine, Paclitaxel, Fluorouracil (5-FU), Oxaliplatin, Tislelizumab
Study Phase: Phase 3

437 Total Publications

Unfamiliar Case of Cardiac Amyloidosis with Sarcoidosis-like Abnormal Magnetic Resonance Imaging Findings.
Unfamiliar Case of Cardiac Amyloidosis with Sarcoidosis-like Abnormal Magnetic Resonance Imaging Findings.
Journal: Internal medicine (Tokyo, Japan)
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kato's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile